Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

NICE set to approve Novartis eye drug Lucentis

NICE set to approve Novartis eye drug Lucentis Patients in England will soon have access to Novartis' Lucentis after it was finally deemed a cost-effective use of NHS resources as a treatment for the eye condition diabetic macular ... new final draft guidance puts Lucentis on course for a second

A new dogma in HTA assessment

A new dogma in HTA assessment Novartis has been a leader in coordinating with payers.  After a legal battle with NICE to appeal a decision regarding the company's wet age-related macular degeneration drug Lucentis, the

Revolution or evolution: is it the end of SMR and ASMR in France?

Revolution or evolution: is it the end of SMR and ASMR in France? An example of this is Lucentis in wet age-related macular degeneration (AMD), where the expectation is that there should be pricing parity between Lucentis and Avastin, an oncology drug used ... off-label; despite data showing increased adverse events


Lucentis campaign. Created by Seven Stones for Novartis. Therapy area: Eye

NICE gives Novartis' Lucentis a final no for diabetic macular oedema

NICE has refused to back Novarits' eye drug Lucentis (ranibizumab), saying its use to treat diabetic macular oedema was not a good use of NHS resources. ... Lucentis costs £742.17 per injection, with treatment given monthly and continued until a patient

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....